These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3193209)

  • 1. Synthesis of "no-carrier-added" carbon-11 SarCNU: the sarcosinamide analog of the chemotherapeutic agent BCNU.
    Conway T; Diksic M
    J Nucl Med; 1988 Dec; 29(12):1957-60. PubMed ID: 3193209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET studies of potential chemotherapeutic agents--X. Synthesis of "no-carrier-added" (11C)-HECNU: the hydroxyethyl analog of the chemotherapeutic agent BCNU.
    Conway T; Diksic M
    Int J Rad Appl Instrum A; 1991; 42(5):441-6. PubMed ID: 1646189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of resistance to (2-chloroethyl)-3-sarcosinamide-1-nitrosourea (SarCNU) in sensitive and resistant human glioma cells.
    Skalski V; Yarosh DB; Batist G; Gros P; Feindel W; Kopriva D; Panasci LC
    Mol Pharmacol; 1990 Sep; 38(3):299-305. PubMed ID: 2402223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of 11C-labelled BCNU and SarCNU in gliomas studied by PET.
    Mitsuki S; Diksic M; Conway T; Yamamoto YL; Villemure JG; Feindel W
    J Neurooncol; 1991 Feb; 10(1):47-55. PubMed ID: 1902507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both extraneuronal monoamine transporter and O(6)-methylguanine-DNA methyltransferase expression influence the antitumor efficacy of 2-chloroethyl-3-sarcosinamide- 1-nitrosourea in human tumor xenografts.
    Chen ZP; Wang ZM; Carter CA; Alley MC; Mohr G; Panasci LC
    J Pharmacol Exp Ther; 2001 Mar; 296(3):712-5. PubMed ID: 11181897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea, a novel chloroethylnitrosourea analogue with enhanced antitumor activity against human glioma xenografts.
    Marcantonio D; Panasci LC; Hollingshead MG; Alley MC; Camalier RF; Sausville EA; Dykes DJ; Carter CA; Malspeis L
    Cancer Res; 1997 Sep; 57(18):3895-8. PubMed ID: 9307267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU) inhibits prostate carcinoma cell growth via p53-dependent and p53-independent pathways.
    Huynh H; Nguyen TH; Panasci L; Do P
    Cancer; 2004 Dec; 101(12):2881-91. PubMed ID: 15529313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cytotoxicity of a 2-chloroethylnitrosourea analog of sarcosinamide in the SK-MG-1 human glioma cell line as a possible indicator for transport.
    Skalski V; Feindel W; Panasci LC
    J Neurooncol; 1989 Jul; 7(2):189-93. PubMed ID: 2476532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of "no-carrier-added" alpha-[11C]methyl-L-tryptophan.
    Chaly T; Diksic M
    J Nucl Med; 1988 Mar; 29(3):370-4. PubMed ID: 3346744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of "no carrier added" 1,3-bis-(2-chloroethyl)nitrosourea (BCNU).
    Diksic M; Farrokhzad S; Yamamoto L; Feindel W
    J Nucl Med; 1982 Oct; 23(10):895-8. PubMed ID: 7119883
    [No Abstract]   [Full Text] [Related]  

  • 11. Transport of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in the human glioma cell line SK-MG-1 is mediated by an epinephrine-sensitive carrier system.
    Noë AJ; Malapetsa A; Panasci LC
    Mol Pharmacol; 1993 Jul; 44(1):204-9. PubMed ID: 8341272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extraneuronal monoamine transporter expression and DNA repair vis-à-vis 2-chloroethyl-3-sarcosinamide-1-nitrosourea cytotoxicity in human tumor cell lines.
    Chen ZP; Remack J; Brent TP; Mohr G; Panasci LC
    Clin Cancer Res; 1999 Dec; 5(12):4186-90. PubMed ID: 10632359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic approaches and bio-distribution studies of [11C]methyl-phenidate.
    Patt M; Solbach C; Wüllner U; Blocher A; Stahlschmidt A; Gündisch D; Kovar KA; Machulla HJ
    J Pharm Pharm Sci; 2007; 10(2):312s-320s. PubMed ID: 17718934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced antitumor activity of sarCNU in comparison to BCNU in an extraneuronal monoamine transporter positive human glioma xenograft model.
    Chen ZP; Wang G; Huang Q; Sun ZF; Zhou LY; Wang AD; Panasci LC
    J Neurooncol; 1999 Aug; 44(1):7-14. PubMed ID: 10582663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered cytotoxicity of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in human glioma cell lines SK-MG-1 and SKI-1 correlates with differential transport kinetics.
    Noë AJ; Malapetsa A; Panasci LC
    Cancer Res; 1994 Mar; 54(6):1491-6. PubMed ID: 8137253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the catecholamine extraneuronal uptake2 carrier in human glioma cell lines SK-MG-1 and SKI-1 in relation to (2-chloroethyl)-3-sarcosinamide-1-nitrosourea (SarCNU) selective cytotoxicity.
    Noë AJ; Marcantonio D; Barton J; Malapetsa A; Panasci LC
    Biochem Pharmacol; 1996 Jun; 51(12):1639-48. PubMed ID: 8687479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The production in high yield of N'-(4-[11C]methyl)-imipramine.
    Denutte H; Goethals P; Cattoir H; Bogaert M; Vandewalle T; Vandecasteele C; Jonckheere J; De Leenheer A
    J Nucl Med; 1983 Dec; 24(12):1185-7. PubMed ID: 6644379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cytotoxicity of sarcosinamide chloroethylnitrosourea (SarCNU) and BCNU in primary gliomas and glioma cell lines: analysis of data in reference to theoretical peak plasma concentrations in man.
    Skalski V; Rivas J; Panasci L; McQuillan A; Feindel W
    Cancer Chemother Pharmacol; 1988; 22(2):137-40. PubMed ID: 3409444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.
    Plisson C; McConathy J; Martarello L; Malveaux EJ; Camp VM; Williams L; Votaw JR; Goodman MM
    J Med Chem; 2004 Feb; 47(5):1122-35. PubMed ID: 14971892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthesis of the 14C labelled anticancer agent: N,N-bis(beta-chloroethyl)-N',N"-di(carboethoxy-[14C] methyl)-phosphorotriamide].
    Guo JY; Huang L; Tian SH; Zhao QR
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Aug; 6(4):295-7. PubMed ID: 6241072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.